ICON Public Limited Company

NASDAQ:ICLR

Medical - Diagnostics & Research

Healthcare
$195.16 -0.19%

-$0.27 today

Market cap
$14.62B
Beta
1.27
P/E (TTM)
23.0
EPS (TTM)
$6.23
52W Low $66.57High $211.00

Volume 0.55M

Average 1.15M

ICLR Common Stock Issued

Cash raised by issuing new shares.

ICON Public Limited CompanyNASDAQ: ICLR

Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026

Common stock issued declines year over year

Q2 FY2026 common stock issued of $1.61M fell 18.7% year over year, ahead of the -74.3% change in trailing-twelve-month common stock issued. Sequentially, it rose 48.1% from the prior quarter. Over 3 fiscal years it compounded at -35.3% a year.

Context

  • Common stock issued amounted to 0.1% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Common stock issued increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -18.7% holds above the trailing-twelve-month pace of -74.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.61M+48.1% QoQ
Last fiscal yearDec 2025
$9.72M-73.1% YoY
LTMJun 2026
$8.56M-74.3% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-18.7%——
1 year-73.1%——
3-year CAGR-35.3%——
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
9.72M USD
Year-over-year change
-73.1%
4-year CAGR
-46.4%

Common Stock Issued vs competitors

How ICLR compares with its peers on the latest reported figures

  • ICLR's LTM Jun 2026 common stock issued of $8.56M is the 4th largest of the 6 companies compared; the peer median is $2.33M.
  • Its year-over-year change of -74.3% is the lowest of 2, against a peer median of +146.3%.
  • Common stock issued amounts to 0.1% of revenue for ICLR, versus a peer median of 0.4%.
ICLR Competitors Peer median
Common Stock Issued for ICLR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$108M ——0.6%
LHLabcorp Holdings Inc.LTM Jun 2026$63.3M +146.3%+2.4%0.4%
MEDPMedpace Holdings, Inc.LTM Sep 2026$48.32M ——1.7%
ICLRICON Public Limited CompanyLTM Jun 2026$8.56M -74.3%-35.3%0.1%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$2.33M ——0.1%
FTREFortrea Holdings Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding ICLR) $2.33M+146.3%+2.4%0.4%

Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income153.19M505.3M612.34M791.47M229.34M
Depreciation & Amortization314.99M569.51M585.95M488.5M383M
Deferred Income Tax(60.62M)(124.99M)(85.4M)0(128.92M)
Stock-Based Compensation133.84M70.52M55.67M45.87M102.04M
Change in Working Capital135M(550.22M)(114.82M)(56.51M)(98.1M)
Accounts Receivables95.86M(753.29M)(78.58M)9.39M(169.32M)
Inventory00000
Accounts Payables00000
Other Working Capital39.14M203.07M(36.24M)(65.9M)71.22M
Other Non-Cash Items152.75M93.18M107.3M17.32M548.85M
Operating Cash Flow829.14M563.32M1.16B1.29B1.04B
Capital Expenditures(93.75M)(142.16M)(140.69M)(168.06M)(174.21M)
Acquisitions (Net)(5.92B)(1.91M)(71.77M)(84.16M)(2.54M)
Purchases of Investments(4.06M)(6.09M)(16.81M)(17.26M)(19.87M)
Sales of Investments497K2.39M2.62M2.69M9.09M
Other Investing Activities(10M)1.91M000
Investing Cash Flow(6.02B)(145.87M)(226.65M)(266.79M)(187.53M)
Debt Repayment5.03B(800M)(895M)(360.28M)(29.76M)
Common Stock Issued117.74M35.84M50.97M36.19M9.72M
Common Stock Repurchased0(99.98M)0(500M)(750M)
Dividends Paid00000
Other Financing Activities(30.33M)(34K)(16K)(13.09M)(1.22M)
Financing Cash Flow5.11B(864.17M)(844.04M)(837.18M)(771.26M)
Effect of Forex Changes(7.73M)(16.72M)(997K)(22M)31.1M
Net Change in Cash(88.09M)(463.45M)89.33M160.68M108.51M
Free Cash Flow735.39M421.16M1.02B1.12B861.99M

ICON Public Limited Company

NASDAQ:ICLR

Intrinsic Alpha fair value

Locked

Current Price

$195.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.